![]() |
|
|
Forward to a colleague |
||
Access Full Stories Four of India's biggest vaccine manufacturers have had their licenses suspended by the Indian government after failing to meet good manufacturing practise (GMP) requirements, according to local media reports... Read Tufts heralds outsourcing as the way of the future The trend towards outsourcing and outside partnering to improve drug development is tipped to continue, with the strategy being heralded as the way of the future in new research produced by the Tufts Center for... Read Missing link to the citric acid cycle found Researchers claim to have found the missing piece in the puzzle of how to artificially recreate the citric acid cycle - an essential part of aerobic respiration. The discovery could lead to plentiful supplies of... Read Icon buys US Phase I base Ireland's Icon has bought itself a Phase I base in the US with the acquisition of Healthcare Discoveries... Read Pharmaceutical contract services round-up Outsourcing-Pharma compiles the latest in motley pharma services news, including PDI, Sentry Logistics Solutions and HCL... Read |
||||||||||||||||||
All News Headlines for: February | January | December |
||||||||||||||||||
![]() Introducing Catalent Pharma Solutions Catalent Pharma Solutions is the leading provider of advanced technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries... Click Here | ||||||||||||||||||
|
Related Industry News FDAs proposed rule on labelling touches pre-emption nerve A proposed rule on labelling changes published by the FDA has re-ignited the reliably inflammable debate over the role of pre-emption in US product liability cases. Critics say the proposal 'shores up the industry's... Read Alpharma pockets $395m for API biz Alpharma has signed a definitive agreement with private equity group 3i for the sale of its active pharmaceutical ingredient (API) business, pocketing $395m in the deal to reinvest in its pharmaceutical and animal... Read Synthesis stumbling blocks in pharma licensing With increasing pressures on pharma pipelines leading to greater interest in compound licensing, firms can be caught out by failing to give scalability issues due attention, according to Joseph D'Antuono speaking... Read Public backs human tissue research Despite adverse publicity in the past, the UK public is becoming increasingly supportive of using human tissues in medical research, according to a new study... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||